Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia

被引:180
|
作者
Fervaha, G. [1 ,2 ]
Foussias, G. [1 ,2 ,3 ]
Agid, O. [1 ,2 ,3 ]
Remington, G. [1 ,2 ,3 ]
机构
[1] Ctr Addict & Mental Hlth, Schizophrenia Div, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
关键词
schizophrenia; functional outcome; negative symptoms; neurocognition; amotivation; avolition-apathy; QUALITY-OF-LIFE; CLINICAL ANTIPSYCHOTIC TRIALS; CONSENSUS COGNITIVE BATTERY; EFFECTIVENESS CATIE PROJECT; RANDOMIZED CONTROLLED-TRIAL; NEGATIVE SYMPTOMS; INTRINSIC MOTIVATION; RATING-SCALE; FOLLOW-UP; APATHY;
D O I
10.1111/acps.12289
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
ObjectiveFunctional impairment is characteristic of most individuals with schizophrenia; however, the key variables that undermine community functioning are not well understood. This study evaluated the association between selected clinical variables and one-year longitudinal functional outcomes in patients with schizophrenia. MethodThe sample included 754 patients with schizophrenia who completed both baseline and one-year follow-up visits in the CATIE study. Patients were evaluated with a comprehensive battery of assessments capturing symptom severity and cognitive performance among other variables. The primary outcome variable was functional status one-year postbaseline measured using the Heinrichs-Carpenter Quality of Life Scale. ResultsFactor analysis of negative symptom items revealed two factors reflecting diminished expression and amotivation. Multivariate regression modeling revealed several significant independent predictors of longitudinal functioning scores. The strongest predictors were baseline amotivation and neurocognition. Both amotivation and neurocognition also had independent predictive value for each of the domains of functioning assessed (e.g., vocational). ConclusionBoth motivational and neurocognitive deficits independently contribute to longitudinal functional outcomes assessed 1year later among patients with schizophrenia. Both of these domains of psychopathology impede functional recovery; hence, it follows that treatments ameliorating each of these symptoms should promote community functioning among individuals with schizophrenia.
引用
收藏
页码:290 / 299
页数:10
相关论文
共 50 条
  • [31] Subjective and objective aspects of neurocognitive deficits in schizophrenia
    Voruganti, L
    Awad, A
    Heslegrave, R
    Parke, G
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 265 - 266
  • [32] Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial
    Richard S E Keefe
    Robert M Bilder
    Philip D Harvey
    Sonia M Davis
    Barton W Palmer
    James M Gold
    Herbert Y Meltzer
    Michael F Green
    Del D Miller
    Jose M Canive
    Lawrence W Adler
    Theo C Manschreck
    Marvin Swartz
    Robert Rosenheck
    Diana O Perkins
    Trina M Walker
    T Scott Stroup
    Joseph P McEvoy
    Jeffrey A Lieberman
    [J]. Neuropsychopharmacology, 2006, 31 : 2033 - 2046
  • [33] Neurocognitive deficits and social functioning in outpatients with schizophrenia
    Dickerson, F
    Boronow, JJ
    Ringel, N
    Parente, F
    [J]. SCHIZOPHRENIA RESEARCH, 1996, 21 (02) : 75 - 83
  • [34] A neurocognitive approach to the study of attention deficits in schizophrenia
    Santiago, E
    Fuentes, LJ
    [J]. PSICOLOGIA CONDUCTUAL, 1999, 7 (03): : 361 - 376
  • [35] Familial risk for neurocognitive deficits associated with schizophrenia
    Jablensky, A
    Michie, P
    Kent, A
    [J]. SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 290 - 290
  • [36] Electrophysiological markers of neurocognitive deficits in paranoid schizophrenia
    Petrov, M.
    Ershov, B.
    Daeva, N.
    Berezina, A.
    Gvozdetsky, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S338 - S338
  • [37] Generalized and specific neurocognitive deficits in prodromal schizophrenia
    Lencz, T
    Smith, CW
    McLaughlin, D
    Auther, A
    Nakayama, E
    Hovey, L
    Cornblatt, BA
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (09) : 863 - 871
  • [38] The influence of neurocognitive deficits and symptoms on disability in schizophrenia
    Ertugrul, A
    Ulug, B
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2002, 105 (03) : 196 - 201
  • [39] Neurocognitive deficits and quality of life in outpatients with schizophrenia
    Aksaray, G
    Oflu, S
    Kaptanoglu, C
    Bal, C
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (06): : 1217 - 1219
  • [40] Neurocognitive deficits, symptoms and quality of life in schizophrenia
    Awad, AG
    Voruganti, LNP
    Heslegrave, RJ
    [J]. SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 272 - 272